TEL AVIV, Israel--(BUSINESS WIRE)--InspireMD announced today the enrollment of 19 patients in its First in Man study in a multi center registry of percutaneous coronary intervention performed with the MGuard™ Coronary stent at the Heart Center in Siegburg, Germany.
